NCT06337097
- Conditions
- Immune Checkpoint Therapy
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Immune Checkpoint Therapy
Explore clinical trials studying Immune Checkpoint Therapy. Study availability and eligibility vary by location and protocol.
9 public trials
7 recruiting studies
Immune Checkpoint Therapy trial results
NCT07279077
- Conditions
- Colon Cancer, Colonic Diseases, Colonic Neoplasms, +12 more
- Locations
-
- The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
NCT07230639
- Conditions
- Immune Checkpoint Therapy, Neoadjuvant Therapies, Radiotherapy
- Locations
-
- The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
NCT06958419
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
- Locations
-
- The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
NCT06958432
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +12 more
- Locations
-
- The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
NCT06923345
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +12 more
- Locations
-
- The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
- Conditions
- Cancer, Immune Checkpoint Therapy, Immunotherapy, +3 more
- Locations
-
- Eastern Connecticut Hematology and Oncology Norwich, Connecticut, United States
- Cancer Center of Middle Georgia Dublin, Georgia, United States
- Carolina Blood and Cancer Care Associates Rock Hill, South Carolina, United States
Enrolling by Invitation
Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals
NCT07088081
- Conditions
- Adenocarcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma, Carcinoma, +14 more
- Locations
-
- Ain Shams University Cairo, Abbasya, Egypt
Not Yet Recruiting
Node-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic pMMR/MSS Gastric Cancer (MODIFI-GC)
NCT06980389
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +8 more
- Locations
-
- The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China